BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32252933)

  • 21. Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
    Richardson PG; Triplett BM; Ho VT; Chao N; Dignan FL; Maglio M; Mohty M
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):113-124. PubMed ID: 29301447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal approach to prevent veno-occlusive disease following hematopoietic stem cell transplantation in children.
    Hassan Z
    Pediatr Transplant; 2010 Sep; 14(6):683-7. PubMed ID: 20353406
    [No Abstract]   [Full Text] [Related]  

  • 23. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.
    Corbacioglu S; Richardson PG
    Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):885-898. PubMed ID: 28825848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of defibrotide in blood and marrow transplantation.
    Richardson PG; Carreras E; Iacobelli M; Nejadnik B
    Blood Adv; 2018 Jun; 2(12):1495-1509. PubMed ID: 29945939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the effects of preconditioning regimens on hepatic veno-occlusive disease in mice after hematopoietic stem cell transplantation.
    Qiao J; Fu J; Fang T; Huang Y; Mi H; Yang N; Chen C; Xu K; Zeng L
    Exp Mol Pathol; 2015 Feb; 98(1):73-8. PubMed ID: 25533545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension.
    Hajouli S; Moustafa MA; Memoli JSW
    J Investig Med High Impact Case Rep; 2019; 7():2324709619840375. PubMed ID: 31010327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperbilirubinemia in the early phase after allogeneic HSCT: prognostic significance of the alkaline phosphatase/total bilirubin ratio.
    Ashizawa M; Oshima K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako K; Machishima T; Kimura S; Kikuchi M; Nakasone H; Okuda S; Kako S; Kanda J; Yamazaki R; Tanihara A; Nishida J; Kanda Y
    Bone Marrow Transplant; 2013 Jan; 48(1):94-8. PubMed ID: 22750996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic Plasma Exchange in Pediatric Patients With Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease After Hematopoietic Stem Cell Transplantation: A Single-Center Experience.
    Akıncı B; Atay D; Demir Yenigürbüz F; Akçay A; Öztürk G
    Exp Clin Transplant; 2022 Jul; 20(7):680-686. PubMed ID: 35607801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Defibrotide therapy for patients with sinusoidal obstruction syndrome after hematopoietic stem cell transplantation].
    Yakushijin K; Okamura A; Ono K; Kawano Y; Kawano H; Funakoshi Y; Kawamori Y; Nishikawa S; Minagawa K; Sada A; Shimoyama M; Yamamoto K; Katayama Y; Matsui T
    Rinsho Ketsueki; 2009 Jan; 50(1):3-8. PubMed ID: 19225222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.
    Faraci M; Bertaina A; Luksch R; Calore E; Lanino E; Saglio F; Prete A; Menconi M; De Simone G; Tintori V; Cesaro S; Santarone S; Orofino MG; Locatelli F; Zecca M
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):313-320. PubMed ID: 30266674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Veno-occlusive disease of the lung after allogeneic haematopoietic stem-cell transplantation: An autopsy study.
    Kreft A; Alverson C; Wagner-Drouet EM; Ries I; Sommer C; Dr Re Nat MS
    Pathol Res Pract; 2022 Mar; 231():153799. PubMed ID: 35180649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Application of defibrotide in hepatic sinusoidal obstruction syndrome induced by hematopoietic stem cell transplantation].
    Liu ZL; Wang Y; Liu YL; Zhang J
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jan; 29(1):92-96. PubMed ID: 33541030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful Treatment of Sinusoidal Obstructive Syndrome with Deceased-Donor Liver Transplant Following Hematopoietic Stem Cell Transplant.
    Yu YD; Kim DS; Yoon YI; Park Y
    Exp Clin Transplant; 2021 Aug; 19(8):880-883. PubMed ID: 33952178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatic veno-occlusive disease after hemopoetic stem cell transplantation].
    Da W; Zhong J; Liu Y
    Zhonghua Nei Ke Za Zhi; 1995 Jun; 34(6):374-7. PubMed ID: 8582182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sinusoidal obstruction disease (SOS), previous hepatic venoocclusive disease (VOD)--still serious complication after hematopoietic stem cell transplantation].
    Gozdzik J; Krasowska-Kwiecień A; Wedrychowicz A
    Przegl Lek; 2008; 65(4):203-8. PubMed ID: 18724548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary veno-occlusive disease: pathogenesis, risk factors, clinical features and diagnostic algorithm - state of the art.
    Szturmowicz M; Kacprzak A; Szołkowska M; Burakowska B; Szczepulska E; Kuś J
    Adv Respir Med; 2018; 86(3):. PubMed ID: 29960280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation.
    Erturk SM; Mortelé KJ; Binkert CA; Glickman JN; Oliva MR; Ros PR; Silverman SG
    AJR Am J Roentgenol; 2006 Jun; 186(6):1497-501. PubMed ID: 16714636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic veno-occlusive disease following peripheral blood stem cell or bone marrow transplantation.
    Salat C; Holler E; Hiller E; Pihusch R; Kolb HJ
    Haematologica; 1999 Jun; 84 Suppl EHA-4():40-3. PubMed ID: 10907464
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation.
    Chalandon Y; Roosnek E; Mermillod B; Newton A; Ozsahin H; Wacker P; Helg C; Chapuis B
    Biol Blood Marrow Transplant; 2004 May; 10(5):347-54. PubMed ID: 15111934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and management of hepatic venoocclusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT).
    Ramasamy K; Lim ZY; Pagliuca A; Grundy R; Devereux S; Ho AY; Mufti GJ
    Bone Marrow Transplant; 2006 Dec; 38(12):823-4. PubMed ID: 17057726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.